Interestingly, our data show that VEGF levels do not modify the expression of miR-20a and, at the same time, that treatment with a VEGFA trap inhibits the angiogenesis induced by luminal breast cancer cells transfected with miR-20a. This evidence concerns the gene VEGFA and breast carcinoma.